NCT02186080View on ClinicalTrials.gov

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

NACompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Gemigliptin

DRUG

Placebo

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

LG Life Sciences

All Listed Sponsors

collaborator

LG Life Sciences

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT02186080 - Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia | Biotech Hunter | Biotech Hunter